Clinical Trial Update: Effect of Early Empagliflozin Initiation in Cardiogenic Shock.

View source ↗

Summary

Update on a clinical trial evaluating early initiation of empagliflozin in patients with cardiogenic shock; the study is currently active but not recruiting in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Cardiogenic Shock | Status: ACTIVE_NOT_RECRUITING